# Efficacy and Safety of Susu Zhike Granules for Treating Acute Cough Due to Common Cold With Cold-cough Syndrome in Children

> **NCT04457011** · PHASE2 · COMPLETED · sponsor: **Tasly Pharmaceutical Group Co., Ltd** · enrollment: 240 (actual)

## Conditions studied

- Cough

## Interventions

- **DRUG:** High dose Susu Xiao'er Zhike Granules 1 bag
- **DRUG:** Middle dose Susu Xiao'er Zhike Granules 1 bag
- **DRUG:** Extremely-low dose Susu Xiao'er Zhike Granules 1 bag

## Key facts

- **NCT ID:** NCT04457011
- **Lead sponsor:** Tasly Pharmaceutical Group Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-19
- **Primary completion:** 2022-02-24
- **Final completion:** 2022-02-24
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2024-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04457011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04457011, "Efficacy and Safety of Susu Zhike Granules for Treating Acute Cough Due to Common Cold With Cold-cough Syndrome in Children". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04457011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*